Skip to main content
Equibles

WELLS FARGO & COMPANY/MN

Position in ZLAB — Zai Lab Ltd

CIK 72971 SAN FRANCISCO, CA
Back to ZLAB Full portfolio

Position in ZLAB

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$1,140
-$100,847 QoQ
Shares Held
60
-98.9% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#83
of 92 holders
Holding Since
Mar 2020
23 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in ZLAB Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

WELLS FARGO & COMPANY/MN holds $1,575,562,942 across 417 Biotechnology names. ZLAB ranks #360 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 749,528 $372,313,040
2 HALO
Halozyme Therapeutics, Inc.
 1,390,428 $108,828,797
3 ALNY
Alnylam Pharmaceuticals, Inc.
 310,047 $93,333,446
4 REGN
Regeneron Pharmaceuticals, Inc.
 140,802 $87,795,677
5 EXEL
Exelixis, Inc.
 717,840 $39,057,673
6 RVMD
Revolution Medicines, Inc.
 178,780 $33,481,916
7 ARGX
Argenx SE
 34,453 $31,964,458
8 INCY
Incyte Corp
 255,064 $28,914,053

All Filings in ZLAB

Export CSV
23 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $1,140 60
2026-03-31 $101,987 5,422
2025-12-31 $1,642,989 93,140
2025-09-30 $5,935,223 175,132
2025-06-30 $6,101,564 174,480
2025-03-31 $5,017,316 138,830
2024-12-31 $1,072,584 40,954
2024-09-30 $12,070 500
2024-06-30 $8,665 500
2024-03-31 $8,010 500
2023-09-30 $3,427 141
2023-03-31 $764 23
2022-09-30 $34,200 1,000
2022-06-30 $63,186 1,822
2022-03-31 $78,679 1,789
2021-12-31 $115,391 1,836
2021-09-30 $32,004,516 303,677
2021-06-30 $102,316,323 578,091
2021-03-31 $75,358,860 564,782
2020-12-31 $74,744,761 552,274
2020-09-30 $44,948,060 540,436
2020-06-30 $36,664,063 446,415
2020-03-31 $29,551,732 574,043